State Street Corp Acquires 36,518 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

State Street Corp increased its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 5.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 680,612 shares of the company’s stock after acquiring an additional 36,518 shares during the period. State Street Corp owned about 0.80% of Stereotaxis worth $1,388,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. SG Americas Securities LLC acquired a new position in Stereotaxis during the third quarter worth $39,000. Rhumbline Advisers grew its holdings in shares of Stereotaxis by 645.6% in the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock worth $88,000 after purchasing an additional 41,780 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock worth $341,000 after purchasing an additional 15,491 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Stereotaxis by 247.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after purchasing an additional 135,041 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in Stereotaxis by 46.2% in the second quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after buying an additional 154,400 shares in the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Price Performance

Shares of NYSEAMERICAN:STXS opened at $2.29 on Friday. Stereotaxis, Inc. has a twelve month low of $1.66 and a twelve month high of $3.29. The firm has a market capitalization of $194.03 million, a PE ratio of -8.18 and a beta of 1.57.

Stereotaxis (NYSEAMERICAN:STXS) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The company had revenue of $9.20 million during the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. Equities analysts anticipate that Stereotaxis, Inc. will post -0.26 earnings per share for the current year.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.